Monday, December 23, 2024
HomeTagsLife Sciences AG

Life Sciences AG

Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, announced that it has strengthened its support to a near-majority holding...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics